Analysis of variation in expression of autosomal dominant osteopetrosis type 2: searching for modifier genes.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bone

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BONE.2005.06.003PMID 16120485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cathepsin L‐deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy

  2004cited by this paper
• Chloride Channel ClCN7 Mutations Are Responsible for Severe Recessive, Dominant, and Intermediate Osteopetrosis

  2003cited by this paper
• Chloride Channel 7 (ClCN7) Gene Mutations and Autosomal Dominant Osteopetrosis, Type II

  2003cited by this paper
• Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.

  2002cited by this paper
• Modifier genes in mice and humans

  2001cited by this paper
• Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

  2001cited by this paper
• Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast Formation*

  2001cited by this paper
• Immunohistochemical detection of parathyroid hormone-related peptide, Indian hedgehog, and patched in the process of endochondral ossification in the human

  2001cited by this paper
• PedCheck: a program for identification of genotype incompatibilities in linkage analysis.

  1998cited by this paper
• Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption

  1998cited by this paper
• The power to detect linkage in complex disease by means of simple LOD-score analyses.

  1998cited by this paper
• Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.

  1996cited by this paper
• Faster sequential genetic linkage computations.

  1993cited by this paper
• Easy calculations of lod scores and genetic risks on small computers.

  1984cited by this paper
• OSTEOPETROSIS: A Clinical, Genetic, Metabolic, and Morphologic Study of the Dominantly Inherited, Benign Form

  1968cited by this paper

• Clinical and genetic diagnosis of autosomal dominant osteopetrosis type II in a Chinese family: A case report

  2023cites this paper
• Responsiveness to endurance training can be partly explained by the number of favorable single nucleotide polymorphisms an individual possesses

  2023cites this paper
• The Role of the Lysosomal Cl−/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration

  2022cites this paper
• CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.

  2022cites this paper
• Molecular basis of bone diseases

  2020cites this paper
• CLCN7 and TCIRG1 mutations in a single family: Evidence for digenic inheritance of osteopetrosis.

  2018cites this paper
• Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADOII) and intermediate autosomal recessive osteopetrosis (ARO) in seven Chinese families

  2017cites this paper
• Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease.

  2017cites this paper
• Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in CLCN7

  2016cites this paper
• Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II)

  2016cites this paper
• A MALIGNANT INFANTILE PSTEOPETROSIS : TWO CASE REPORTS

  2016cites this paper
• Novel CLCN7 mutation identified in a Han Chinese family with autosomal dominant osteopetrosis-2

  2016cites this paper
• Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients

  2016cites this paper
• Biomarker Genes in Autosomal Dominant Osteopetrosis Type II (ADO II)

  2015cites this paper
• Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology

  2014cites this paper
• Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models.

  2014cites this paper
• Identification of TCIRG1 and CLCN7 gene mutations in a patient with autosomal recessive osteopetrosis.

  2014cites this paper
• Mise en évidence de deux nouvelles mutations du gène CLCN7 par l’étude de trois familles chinoises atteintes d’une ostéopétrose autosomique dominante de type II☆

  2014cites this paper
• Identification of two novel CLCN7 gene mutations in three Chinese families with autosomal dominant osteopetrosis type II.

  2014cites this paper
• Autosomal dominant osteopetrosis revisited: lessons from recent studies.

  2013cites this paper
• Identification of potential microRNA–target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics

  2013cites this paper
• Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

  2013cites this paper
• The virulence gene and clinical phenotypes of osteopetrosis in the Chinese population: six novel mutations of the CLCN7 gene in twelve osteopetrosis families

  2012cites this paper
• Novel mutation of TCIRG1 and clinical pictures of two infantile malignant osteopetrosis patients

  2011cites this paper
• Genetics of bone diseases: Paget's disease, fibrous dysplasia, osteopetrosis, and osteogenesis imperfecta.

  2011cites this paper
• Génétique des maladies osseuses

  2010cites this paper
• CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration.

  2009cites this paper
• Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II)

  2009cites this paper
• Genetics, pathogenesis and complications of osteopetrosis.

  2008cites this paper
• CLCN7 polymorphisms and bone mineral density in healthy premenopausal white women and in white men.

  2008cites this paper
• Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.

  2007cites this paper
• Disease Status in Autosomal Dominant Osteopetrosis Type 2 Is Determined by Osteoclastic Properties

  2006cites this paper
• Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II.

  2006cites this paper